Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Non-Current Assets (2018 - 2026)

Exagen filings provide 9 years of Non-Current Assets readings, the most recent being $8.4 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 7.51% to $8.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $35.5 million, a 8.98% increase, with the full-year FY2025 number at $9.1 million, up 10.87% from a year prior.
  • Non-Current Assets hit $8.4 million in Q1 2026 for Exagen, down from $9.1 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $19.5 million in Q3 2022 to a low of $7.8 million in Q2 2025.
  • Median Non-Current Assets over the past 5 years was $9.1 million (2025), compared with a mean of $11.4 million.
  • Biggest five-year swings in Non-Current Assets: soared 125.78% in 2022 and later crashed 38.48% in 2023.
  • Exagen's Non-Current Assets stood at $13.6 million in 2022, then tumbled by 33.12% to $9.1 million in 2023, then decreased by 9.55% to $8.2 million in 2024, then rose by 10.87% to $9.1 million in 2025, then dropped by 8.27% to $8.4 million in 2026.
  • The last three reported values for Non-Current Assets were $8.4 million (Q1 2026), $9.1 million (Q4 2025), and $10.2 million (Q3 2025) per Business Quant data.